03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Adenocor : | |
Type | TAU |
Originator | B |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Sanofi |
Manufacturer | GlaxoWellcome Production |
Origin | France |
ATC | C01EB10 |
Adenocor :
Adenocor :
Adenocor :
Adenocor :
Adenocor :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Adenocor :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Apnoea (Apnea) | Not known |
Apprehension | Common |
Asystole | Not known |
Atrial extrasystoles | Very Common |
Atrial fibrillation | Very rare |
Atrioventricular block (AVB) | Very Common |
Bradycardia | Very Common |
Bronchospasm | Very rare |
Burning sensation | Common |
Cardiac arrest | Not known |
Cardiac disorder | Not known |
Chest pain | Very Common |
Chest pressure | Very Common |
Chest tightness | Very Common |
Convulsion | Not known |
Dizziness | Common |
Dyspnoea (dyspnea) | Very Common |
Flushing | Very Common |
General discomfort | Uncommon |
Head pressure | Uncommon |
Headache | Common |
Hyperventilation | Uncommon |
Hypotension | Not known |
Injection site reaction | Very rare |
Intracranial hypertension (Intracranial pressure increased) | Very rare |
Lightheadedness | Common |
Loss of consciousness | Not known |
Nausea | Common |
Pain | Uncommon |
Palpitations | Uncommon |
Respiratory arrest | Not known |
Respiratory failure | Not known |
Sinus arrest (Sinus pause) | Very Common |
Sinus tachycardia | Uncommon |
Skipped beats | Very Common |
Sweating | Uncommon |
Syncope | Not known |
Taste metallic | Uncommon |
Torsade de pointes | Very rare |
Ventricular extrasystoles | Very Common |
Ventricular fibrillation | Very rare |
Ventricular tachycardia | Very Common |
Vision blurred | Uncommon |
Vomiting | Not known |
Weakness | Uncommon |
Adenocor :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Adenocor MoH 2060843 :
Form | Solution for injection |
Packaging | Bottle |
Package Size | 6x2ml |
Strength | 6mg |
Storage Condition | 15-25°C Do not refrigerate |
Stratum | N/A |
NSSF | ✘ |
Quarantine | ✘ |
Price Comparison
● Country: | Finland | |
● Package Size: | 6x2ml | |
● Public Price: | 267.95 EUR | ( 25,957,924.20 LBP ) |
● Pack size unit used: | 6 | |
● Cost/Unit: | 44,6583 EUR | ( 4,262,544.00 LBP ) |
● Reference: | Kela | |
● Pricing Date: | 24/10/2020 | |
● Type: | Medicine Non Marketed |
● Country: | Abu Dhabi | |
● Package Size: | 6x2ml | |
● Public Price: | 384 AED | ( 9,277,824.00 LBP ) |
● Pack size unit used: | 6 | |
● Cost/Unit: | 64 AED | ( 1,546,304.00 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Denmark | |
● Package Size: | 6x2ml | |
● Public Price: | 440.65 DKK | ( 5,717,874.40 LBP ) |
● Pack size unit used: | 6 | |
● Cost/Unit: | 73,4417 DKK | ( 947,248.00 LBP ) |
● Pharmacy Price: | 322.55 DKK | ( 4185408.8 LBP ) |
● Reference: | Danish Medicine Agency | |
● Pricing Date: | 19/05/2021 | |
● Type: | Medicine Authorised |
● Country: | KSA | |
● Package Size: | 2ml | |
● Public Price: | 170.5 SAR | ( 4,030,620.00 LBP ) |
● Pack size unit used: | 6 | |
● Cost/Unit: | 28,4167 SAR | ( 661,920.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 16/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Czech Republic | |
● Package Size: | 6x2ml | |
● Public Price: | 804.3 CZK | ( 3,071,621.70 LBP ) |
● Pack size unit used: | 6 | |
● Cost/Unit: | 134,05 CZK | ( 511,746.00 LBP ) |
● Reference: | SUKL | |
● Pricing Date: | 28/02/2020 | |
● Type: | Medicine Authorised |
● Country: | Spain | |
● Package Size: | 6x2ml | |
● Public Price: | 35.42 EUR | ( 3,431,347.92 LBP ) |
● Pack size unit used: | 6 | |
● Cost/Unit: | 5,9033 EUR | ( 484,380.00 LBP ) |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Bahrain | |
● Package Size: | 6x2ml | |
● Public Price: | 15.16 BHD | ( 3,604,047.44 LBP ) |
● Pack size unit used: | 6 | |
● Cost/Unit: | 2,5267 BHD | ( 475,468.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 09/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 6x2ml | |
● Public Price: | 21 EUR | ( 2,034,396.00 LBP ) |
● Pack size unit used: | 6 | |
● Cost/Unit: | 3,5 EUR | ( 290,628.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 02/12/2020 | |
● Type: | Medicine Authorised |
● Country: | Greece | |
● Package Size: | 6x2ml | |
● Public Price: | 14.48 EUR | ( 1,402,764.48 LBP ) |
● Pack size unit used: | 6 | |
● Cost/Unit: | 2,4133 EUR | ( 193,752.00 LBP ) |
● Exfactory Price: | 10.02 EUR | |
● Pharmacy Price: | 10.51 EUR | ( 1018166.76 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 6x2ml | |
● Public Price: | 7.77 JOD | ( 972,967.17 LBP ) |
● Pack size unit used: | 6 | |
● Cost/Unit: | 1,295 JOD | ( 125,221.00 LBP ) |
● Pharmacy Price: | 7.47 JOD | ( 935400.87 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 02/01/2021 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 6x2ml | |
● Public Price: | 6.45 GBP | ( 733,036.05 LBP ) |
● Pack size unit used: | 6 | |
● Cost/Unit: | 1,075 GBP | ( 113,649.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | New Zealand |
● Package Size: | 6 inj |
● Exfactory Price: | 62.73 NZD |
● Reference: | New Zealand Pharmaceutical Management Agency |
● Pricing Date: | 01/04/2020 |
● Type: | Medicine Authorised |
Note
You have to register to view this info
Drop File